Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHILD@HOME_BJI: Oral-only Antibiotics for Bone and Joint Infections
NCT04563325Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- Sep 2020
- Primary completion
- Jan 2024
- Modality
- Irreversible Covalent Inhibitors, Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amoxicillin + clavulanate and dicloxacillin in osteomyelitis (OM) and septic arthritis (2 arms), sponsored by Rigshospitalet. Primary endpoint: Sequelae at 6 months. Started Sep 2020; status: completed.
02
Drugs
amoxicillin + clavulanatedicloxacillin
03
Conditions
osteomyelitis (OM)septic arthritis
Beyond the preview
Go deeper on NCT04563325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04563325.